全文获取类型
收费全文 | 5679篇 |
免费 | 511篇 |
国内免费 | 310篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 87篇 |
妇产科学 | 113篇 |
基础医学 | 734篇 |
口腔科学 | 118篇 |
临床医学 | 728篇 |
内科学 | 962篇 |
皮肤病学 | 82篇 |
神经病学 | 321篇 |
特种医学 | 223篇 |
外科学 | 727篇 |
综合类 | 831篇 |
现状与发展 | 2篇 |
一般理论 | 1篇 |
预防医学 | 295篇 |
眼科学 | 128篇 |
药学 | 491篇 |
1篇 | |
中国医学 | 210篇 |
肿瘤学 | 415篇 |
出版年
2024年 | 19篇 |
2023年 | 89篇 |
2022年 | 201篇 |
2021年 | 239篇 |
2020年 | 191篇 |
2019年 | 161篇 |
2018年 | 208篇 |
2017年 | 172篇 |
2016年 | 167篇 |
2015年 | 224篇 |
2014年 | 286篇 |
2013年 | 254篇 |
2012年 | 418篇 |
2011年 | 475篇 |
2010年 | 255篇 |
2009年 | 240篇 |
2008年 | 308篇 |
2007年 | 303篇 |
2006年 | 277篇 |
2005年 | 284篇 |
2004年 | 221篇 |
2003年 | 197篇 |
2002年 | 149篇 |
2001年 | 137篇 |
2000年 | 142篇 |
1999年 | 159篇 |
1998年 | 96篇 |
1997年 | 77篇 |
1996年 | 73篇 |
1995年 | 65篇 |
1994年 | 58篇 |
1993年 | 36篇 |
1992年 | 47篇 |
1991年 | 39篇 |
1990年 | 38篇 |
1989年 | 30篇 |
1988年 | 24篇 |
1987年 | 24篇 |
1986年 | 23篇 |
1985年 | 14篇 |
1984年 | 14篇 |
1983年 | 11篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1979年 | 10篇 |
1973年 | 2篇 |
1972年 | 4篇 |
1971年 | 3篇 |
1970年 | 6篇 |
1969年 | 6篇 |
排序方式: 共有6500条查询结果,搜索用时 15 毫秒
61.
瘤内注射重组人p53腺病毒治疗晚期肺癌临床试验观察 总被引:1,自引:0,他引:1
目的 观察重组人p53腺病毒注射液(rAd-p53)在晚期肺癌治疗中的疗效和毒副反应。方法 12例IIIb-IV期肺癌及3例肺转移癌,CT定位经皮肺穿刺瘤内注射rAd-p53,1 次/周×4/疗程;通过临床观察、CT及病理对照及短期随访进行评价。结果 治疗后2 月观察肿瘤缩小5例(33.3%),无变化7例(46.7%),增大3例(20%);治疗后病理观察:癌组织坏死,癌细胞稀少(6/11,54.5%);除自限性发热外,无明显毒副反应。结论rAd-p53瘤内注射治疗肺癌,无明显毒副作用,能较好地抑制局部肿瘤的发展,尤其对失去手术机会,不能耐受放化疗的患者,是一种可行的有前景的方法。 相似文献
62.
Wen-Kai Weng Debra Czerwinski John Timmerman Frank J Hsu Ronald Levy 《Journal of clinical oncology》2004,22(23):4717-4724
PURPOSE: The unique immunoglobulin idiotype (Id) expressed by each B-cell lymphoma is a target for immunotherapy. Vaccination with Id induces humoral and/or cellular anti-Id immune responses. However, the clinical impact of these anti-Id immune responses is unknown. We and others have previously reported that immunoglobulin G Fc receptor (FcgammaR) polymorphisms predict the clinical response of lymphoma patients to passive anti-CD20 antibody infusions. In this study, we tested whether anti-Id immune responses or FcgammaR polymorphisms associate with clinical outcome of patients who received Id vaccination. PATIENTS AND METHODS: We analyzed 136 patients with follicular lymphoma who had received Id vaccination. The anti-Id immune responses were measured and FcgammaRIIIa and FcgammaRIIa polymorphisms were determined and correlated with clinical outcome for these patients. RESULTS: Patients who mounted humoral immune responses had a longer progression-free survival (PFS) than those who did not (8.21 v 3.38 years; P = .018). Patients with FcgammaRIIIa 158 valine/valine (V/V) genotype also had a longer PFS than those with valine/phenylalanine (V/F) or phenylalanine/phenylalanine (F/F) genotypes (V/V, 8.21 v V/F, 3.38 years; P = .004; v F/F, 4.47 years; P = .035). Multivariate analysis using the Cox proportional hazards model showed that V/V genotype and humoral immune responses were independent positive predictors for PFS. CONCLUSION: This study is the first to identify the predictive value of FcgammaR polymorphism on clinical outcome in patients who received active immunotherapy with tumor antigen vaccines. Our results imply that the antibodies induced against a tumor antigen are beneficial and that FcgammaR-bearing cells mediate an antitumor effect by killing antibody-coated tumor cells. 相似文献
63.
Chew BP Park JS Weng BC Wong TS Hayek MG Reinhart GA 《The Journal of nutrition》2000,130(9):2322-2325
Three experiments were conducted to study the uptake of oral beta-carotene by blood plasma and leukocytes in domestic cats. In Experiment 1, mature female Tabby cats (12 mo old) were given once orally 0, 10, 20 or 50 mg of beta-carotene and blood taken at 0, 12, 24, 30, 36, 42, 48 and 72 h after dosing. Concentrations of plasma beta-carotene increased in a dose-dependent manner. Peak concentrations were observed at 12-24 h and declined gradually thereafter. The half-life of plasma beta-carotene was 12-30 h. In Experiment 2, cats were dosed daily for six consecutive days with 0, 1, 2, 5 or 10 mg beta-carotene. Blood was sampled once daily at 12 h after each feeding. Daily dosing of cats with beta-carotene for 6 d resulted in a dose-dependent increase in circulating beta-carotene. Experiment 3 was designed to study the uptake of beta-carotene by blood leukocytes. Cats were fed 0, 5 or 10 mg of beta-carotene daily for 14 d. Blood leukocytes were obtained on d 7 and 14 to determine beta-carotene content in whole lymphocytes and in subcellular fractions. Blood lymphocytes took up large amounts of beta-carotene by d 7 of feeding. Furthermore, beta-carotene accumulated mainly in the mitochondria (40-52%), with lower amounts accumulating in the microsomes (20-35%), cytosol (15-34%), and nuclei (1.5-6%). Therefore, domestic cats readily absorb beta-carotene across the intestinal mucosa and transfer the beta-carotene into peripheral blood leukocytes and their subcellular organelles. beta-Carotene uptake kinetics show that some aspects of beta-carotene absorption and metabolism in cats are similar to those of humans. 相似文献
64.
止痛活血化瘀药实验研究 总被引:5,自引:0,他引:5
本文研究了止痛活血化瘀药对血液流变性的影响。两类止痛活血化瘀药在改善红细胞聚集性、变形性等血液流变性诸参数的作用是明显不同的。结果表明活血散瘀类药可明显改善四项红细胞流变性参数,即通过降低红细胞表明电荷以增加细胞间的排斥力,防止红细胞聚集,改善变形性,降低纤维蛋白元含量,降低血液粘度,改善血液流变性。另一方面,祛风行气类药则可降低血小板聚集性和粘附性。因此,止痛活血化瘀药的作用机理是不同的 相似文献
65.
66.
肺癌手术患者医院感染的病原菌及相关因素临床分析 总被引:3,自引:0,他引:3
背景与目的肺癌是我国最常见的恶性肿瘤之一,外科手术切除仍然是肺癌患者治疗的首选方法。手术后患者的预后与很多因素相关,其中之一就是手术后医院感染。本研究目的在于探讨肺癌手术患者医院感染病原菌的分布及其相关因素,为预防患者手术后医院感染及改善患者预后提供帮助。方法回顾分析1227例肺癌手术患者中113例医院感染病例,并进行统计学处理。结果肺癌患者医院感染病原菌检出率:革兰氏阴性杆菌为64.03%(299/467),以铜绿假单胞菌为主;革兰氏阳性球菌为31.05%(145/467),以金黄色葡萄球菌为主;真菌为4.92%(23/467)。药敏试验结果提示:产超广谱82内酰胺酶菌(ESBLs)和耐甲氧西林葡萄球菌(MRS)检出率都很高,导致医院感染致病菌对多种抗生素均有较高的耐药性。老年,肥胖,有长期吸烟史,伴发糖尿病、肾功能不全以及使用人工辅助呼吸24h以上为肺癌手术患者发生医院感染的正相关因素。结论对肺癌患者手术后医院感染的相关因素及病原菌应有足够的认识。临床用药应根据致病菌药敏试验结果合理选择使用抗生素,同时强调抗生素的合理使用,以控制致病菌的耐药性。 相似文献
67.
肺癌肺叶袖状切除术的安全性和有效性 总被引:12,自引:2,他引:12
目的:评价肺癌肺叶袖状切除术后患者的手术安全性和远期生存状况.方法:回顾分析了1999年10月至2003年12月行肺癌根治术的94名病例,其中肺叶袖状切除术11例(Ⅰ组),全肺切除术17例(Ⅱ组),肺叶切除术66例(Ⅲ组).通过比较三组术后气管插管时间、ICU停留时间、吻合口并发症率及围手术期死亡率,评价肺叶袖状切除术的手术安全性,比较Ⅰ、Ⅱ组间的生存期和转移复发率探讨其远期有效性.组间率比较用x2检验或Fisher精确检验,均数比较用t检验,生存分析用Kaplan-Meier法,生存曲线比较用Log rank检验.显著性差异标准α=0.05.结果:Ⅰ、Ⅱ、Ⅲ组的手术死亡率为0,11.8%,3.0%,组间无显著性差异;平均气管插管时间为0.5±2.3天,2.0±7.2天,0.6±4.1天(Ⅰ、ⅢVSⅡ组,P<0.05);吻合口并发症率为3.0%,0,5.8%,组间无显著性差异.Ⅰ组1年、3年生存率为45.5%、32.5%,Ⅱ组为58.8%、45.8%.两组生存率、远期局部复发率和转移率无显著性差异.结论:肺癌肺叶袖状切除术具有和肺叶切除术相近的手术安全性,优于全肺切除术,而其复发转移率、远期疗效与后者相近,是安全有效的手术方式. 相似文献
68.
Bioavailability of long-chain omega-3 polyunsaturated fatty acid enriched luncheon meats 总被引:1,自引:0,他引:1
(Nutr Diet 2005;62:130–137) Objective: To determine the acute and chronic effects of low doses of long chain (LC) n‐3 polyunsaturated fatty acids (PUFA) on plasma LC n‐3 PUFA levels. Design: In the acute study, six healthy omnivores, avoiding fish meals on the day prior to the study, provided a fasting blood sample initially and post prandially at four hours. In the chronic study, 12 healthy subjects provided a fasting blood sample at baseline and three weeks after daily consumption of the test food. Main outcome measures: Plasma non‐esterified fatty acid and phospholipid LC n‐3 PUFA composition. Statistical analysis: Differences in plasma non‐esterified fatty acids and phospholipid LC n‐3 PUFA. A pre‐ and post‐consumption of the test food were assessed using paired t‐tests (spss ). Results: The acute study demonstrated that a low dose of LC n‐3 PUFA (25% eicosapentaenoic acid and 75% docosahexaenoic acid) significantly increased eicosapentaenoic acid levels in plasma of human subjects postprandially from 0.30% to 0.42% of total non‐esterified fatty acids, a per cent change of 39% (P < 0.05). The chronic study demonstrated a significant increase in total n‐3 phospholipids from zero weeks (5.48% of total fatty acids) to three weeks (7.92% of total fatty acids), representing a per cent increase of 44% (P = 0.006). The n‐6 to n‐3 ratio of LC PUFA phospholipids demonstrated a significant reduction from 5.1 at zero weeks to 4.07 at three weeks, representing a reduction of 20% (P = 0.006). Conclusions: These findings demonstrate the bioavailability of LC n‐3 PUFA consumed as a low‐fat omega‐3‐enriched luncheon meat. 相似文献
69.
Mi ZP Jiang P Weng WL Lindberg FP Narayanan V Lagenaur CF 《The Journal of comparative neurology》2000,416(3):335-344
P84 and integrin associated protein (IAP) are heterophilic binding partners that are expressed in the central nervous system in addition to a variety of other tissues. Both molecules are known to be involved in cell signaling in nonneural tissues. In the retina, both molecules are expressed prominently in plexiform layers, suggesting a possible association with synapses. Here, we examined the cellular expression and ultrastructural localization of the two molecules in the developing mouse retina. Both appeared to be expressed at one or both sides of synaptic sites, although the expression of IAP in the retina precedes that of P84. Examination of transgenic IAP-null retinae revealed a failure of P84 to become associated with synaptic sites, suggesting the interaction of P84 with IAP was necessary for P84's synaptic localization. These findings suggest that the signaling activities of P84 and IAP are localized to sites of synaptic contact in the retina. Thus this pair of synapse-associated molecules represents a bidirectional signaling system that could function to modify synaptic activity or possibly trophic interactions between central neurons. 相似文献
70.
目的提高重症急性胰腺炎的疗效。方法回顾性分析近10年来14例经手术治疗的SAP患者临床资料。结果14例患者中,合并休克者10例,胰脑病2例,MOF2例,ARDS2例,病死率为28%(4/14)。结论降低死亡率的关键在于围手术期的正确处理,特别是病程早期。首先,应加强围手术期的个体化监护,进行综合治疗,其次,抑制胰腺的外分泌;第三,早期使用足量的有效抗生素;第四,进行周围静脉的营养支持;第五,加强围手术期并发症的防治。 相似文献